On the other hand, soluble CD44, CD44v6, CD44v8-10, and EpCAM were not suitable to distinguish between recurrence and non-recurrence in patients with late stage CCA (Additional file 3: Fig. S2). This evidence concerns the gene EPCAM and cholangiocarcinoma.